Repurposing Heparin as Antimalarial: Evaluation of Multiple Modifications Toward In Vivo Application.

Pharmaceutics · 2020 · PMC7557421 · PMID 32872434

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Overall, longer-chain heparin molecules of molecular weight >3 to 25 kDa showed a trend toward having higher inhibitory activity than shorter-chain forms <3 kDa [ 20 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.